Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via WNT/Β-Catenin Signaling Pathway

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s208458

Related search